[1]
Perumal, R. et al. 2023. Clinical impact of plasma concentrations of first-line antituberculosis drugs. South African Medical Journal. 113, 3 (Mar. 2023), 148–153. DOI:https://doi.org/10.7196/SAMJ.2023.v113i3.16761.